|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | ||
| Stock-based compensation expense | ||
| Change in fair value of preferred stock tranche right liability | ||
| Net amortization of premiums and accretion of discounts on short-term investments | ||
| Non-cash lease expense | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Prepaid expenses and other assets | ||
| Accounts payable | ||
| Accrued expenses and other current liabilities | ||
| Operating lease liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Purchases of short-term investments | ||
| Maturities of short-term investments | ||
| Purchases of equipment | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from the issuance of Series B redeemable convertible preferred stock, net of issuance costs paid | ||
| Series B Redeemable Convertible Preferred Stock | ||
| Total proceeds from the issuance of Series B redeemable convertible preferred stock, net of issuance costs paid | ||
| Proceeds from initial public offering, net of underwriters discounts and commissions | ||
| Payments of initial public offering costs | ||
| Proceeds from exercises of stock options | ||
| Proceeds from issuance of common stock under employee stock purchase plan | ||
| Net cash provided by financing activities | ||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash at beginning of period | ||
| Cash, cash equivalents and restricted cash at end of period | ||
| Cash, cash equivalents and restricted cash at end of period: | ||
| Cash and cash equivalents | ||
| Restricted cash | ||
| Total cash, cash equivalents and restricted cash at end of period | ||
| Supplemental cash flow information: | ||
| Right-of-use asset obtained in exchange for operating lease liability | ||
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Settlement of preferred stock tranche right liability | ||
| Initial public offering costs included in accounts payable |
Loading...
